Artificial tears drug is used for the treatment of dry eye syndrome and allergic conjunctivitis. OTC artificial tears help to maintain moisture and well-being mostly in geriatric patients, who are vulnerable to dry eye syndrome due to intake of many medications and dysfunctions of lacrimal gland. This study comprises products only and not the services. The study estimates the revenue generated from the sales of OTC artificial tears. The valuations comprise revenue generated from adoption of OTC artificial tears by patients. The study scope focuses on OTC artificial drugs for hospital pharmacies, drug stores, and online pharmacies.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET LANDSCAPE

CHAPTER 4: OTC ARTIFICIAL TEARS MARKET, BY PRODUCT TYPE

CHAPTER 5: OTC ARTIFICIAL TEARS MARKET, BY CONTAINER TYPE

CHAPTER 6: OTC ARTIFICIAL TEARS MARKET, BY FORMULATION

CHAPTER 7: OTC ARTIFICIAL TEARS MARKET, BY APPLICATION

CHAPTER 8: OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 9: OTC ARTIFICIAL TEARS MARKET, BY REGION

CHAPTER 10: COMPANY PROFILES